Ticker Details
Haemonetics Corporation Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$3.41B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.79 | 1.25%
Avg Daily Range (30 D):	$1.32 | 1.83%
Avg Daily Range (90 D):	$1.22 | 1.95%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	9,489
Avg Institutional Trade:	$2.82M
Avg Institutional Trade (30 D):	$5.48M
Avg Institutional Trade (90 D):	$4.39M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.09M
Avg Closing Trade (30 D):	$13.07M
Avg Closing Trade (90 D):	$9.4M
Avg Closing Volume:	58.08K

News

Jun 25, 2026 @ 2:30 AM [Latest] Global Therapeutic Apheresis Market Size/... Source: Healthcare Foresights

Jan 9, 2026 @ 1:16 PM Haemonetics Expands Heart Surgery Arsenal With Viv... Source: Akanksha Bakshi

Aug 14, 2025 @ 2:58 PM Patient Blood Management Market Growth Analysis Re... Source: Researchandmarkets.Com

Aug 7, 2025 @ 10:33 AM Haemonetics (HAE) Q1 Revenue Falls 4% Source: Jesterai

Feb 28, 2025 @ 6:00 PM Global Blood Bank Market to Register Immense Growt... Source: Delveinsight

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$2.06	$-.41	$2.06
Diluted EPS	$2.05	$-.41	$2.05
Revenue	$1.33B	$346.35M	$1.33B
Gross Profit	$787.59M	$198.21M	$787.59M
Net Income / Loss	$97.31M	$-20.15M	$97.31M
Operating Income / Loss	$156.73M	$-23.03M	$156.73M
Cost of Revenue	$546.44M	$148.14M	$546.44M
Net Cash Flow	$-61.32M	$-117.93M	$-61.32M
PE Ratio

Splits
Dec 03, 2012	2:1